Orbimed Advisors as of June 30, 2023
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 121 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sinovac Biotech SHS (SVA) | 6.1 | $340M | 2.7M | 125.06 | |
Intuitive Surgical Com New (ISRG) | 3.8 | $212M | 621k | 341.94 | |
Enliven Therapeutics (ELVN) | 3.3 | $184M | 9.0M | 20.41 | |
Boston Scientific Corporation (BSX) | 3.3 | $183M | 3.4M | 54.09 | |
Baxter International Call Option (BAX) | 3.0 | $167M | 3.7M | 45.56 | |
Humana (HUM) | 3.0 | $167M | 374k | 447.13 | |
Theseus Pharmaceuticals | 2.9 | $161M | 17M | 9.33 | |
Biogen Idec (BIIB) | 2.9 | $159M | 557k | 284.85 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $140M | 1.6M | 86.68 | |
UnitedHealth (UNH) | 2.1 | $117M | 244k | 480.64 | |
Edgewise Therapeutics (EWTX) | 2.0 | $113M | 15M | 7.75 | |
Acelyrin (SLRN) | 2.0 | $111M | 5.3M | 20.90 | |
Springworks Therapeutics (SWTX) | 2.0 | $110M | 4.2M | 26.22 | |
Disc Medicine (IRON) | 1.8 | $101M | 2.3M | 44.40 | |
Bristol Myers Squibb (BMY) | 1.7 | $95M | 1.5M | 63.95 | |
Ionis Pharmaceuticals (IONS) | 1.6 | $89M | 2.2M | 41.03 | |
United Therapeutics Corporation (UTHR) | 1.6 | $89M | 402k | 220.75 | |
Evolent Health Cl A (EVH) | 1.6 | $88M | 2.9M | 30.30 | |
Vectivbio Hldg Ord Shs | 1.6 | $88M | 5.2M | 17.00 | |
Eli Lilly & Co. (LLY) | 1.6 | $87M | 186k | 468.98 | |
Tenet Healthcare Corp Com New (THC) | 1.6 | $86M | 1.1M | 81.38 | |
Thermo Fisher Scientific (TMO) | 1.5 | $85M | 163k | 521.75 | |
Apellis Pharmaceuticals (APLS) | 1.5 | $83M | 910k | 91.10 | |
Stryker Corporation (SYK) | 1.5 | $83M | 271k | 305.09 | |
Verona Pharma Sponsored Ads (VRNA) | 1.4 | $80M | 3.8M | 21.14 | |
Ikena Oncology Nonvoting | 1.4 | $78M | 12M | 6.56 | |
Sarepta Therapeutics (SRPT) | 1.4 | $75M | 654k | 114.52 | |
Madrigal Pharmaceuticals (MDGL) | 1.3 | $74M | 322k | 231.00 | |
Crinetics Pharmaceuticals In (CRNX) | 1.3 | $71M | 4.0M | 18.02 | |
Compass Therapeutics (CMPX) | 1.3 | $71M | 22M | 3.18 | |
Xtant Med Hldgs Com New (XTNT) | 1.2 | $68M | 73M | 0.93 | |
Terns Pharmaceuticals (TERN) | 1.2 | $67M | 7.6M | 8.75 | |
R1 RCM (RCM) | 1.1 | $64M | 3.4M | 18.45 | |
Si-bone (SIBN) | 1.1 | $62M | 2.3M | 26.98 | |
Keros Therapeutics (KROS) | 1.1 | $61M | 1.5M | 40.18 | |
Silverback Therapeutics (SPRY) | 1.1 | $59M | 8.7M | 6.70 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $58M | 165k | 351.91 | |
Scpharmaceuticals (SCPH) | 1.0 | $57M | 5.6M | 10.19 | |
Syndax Pharmaceuticals (SNDX) | 1.0 | $53M | 2.5M | 20.93 | |
Vaxcyte (PCVX) | 0.9 | $50M | 1.0M | 49.94 | |
Prelude Therapeutics (PRLD) | 0.9 | $49M | 11M | 4.50 | |
Edwards Lifesciences (EW) | 0.9 | $49M | 515k | 94.33 | |
Natera (NTRA) | 0.9 | $47M | 974k | 48.66 | |
Neurocrine Biosciences (NBIX) | 0.8 | $46M | 489k | 94.30 | |
Cigna Corp (CI) | 0.8 | $45M | 161k | 280.60 | |
Xenon Pharmaceuticals (XENE) | 0.8 | $42M | 1.1M | 38.50 | |
Alpine Immune Sciences | 0.8 | $42M | 4.1M | 10.28 | |
Pmv Pharmaceuticals (PMVP) | 0.7 | $41M | 6.6M | 6.26 | |
Horizon Therapeutics Pub L SHS | 0.7 | $38M | 366k | 102.85 | |
Zimmer Holdings (ZBH) | 0.6 | $36M | 245k | 145.60 | |
Repare Therapeutics Ord (RPTX) | 0.6 | $35M | 3.3M | 10.58 | |
Gracell Biotechnologies Sponsored Ads | 0.6 | $34M | 9.0M | 3.81 | |
Janux Therapeutics (JANX) | 0.6 | $34M | 2.8M | 11.87 | |
Iovance Biotherapeutics (IOVA) | 0.6 | $33M | 4.7M | 7.04 | |
Mirati Therapeutics | 0.6 | $33M | 914k | 36.13 | |
Travere Therapeutics (TVTX) | 0.6 | $33M | 2.1M | 15.36 | |
Tela Bio (TELA) | 0.5 | $29M | 2.8M | 10.13 | |
Amgen (AMGN) | 0.5 | $28M | 127k | 222.02 | |
Vera Therapeutics Cl A (VERA) | 0.5 | $28M | 1.8M | 16.05 | |
Third Harmonic Bio (THRD) | 0.5 | $28M | 5.8M | 4.81 | |
Abcellera Biologics (ABCL) | 0.5 | $27M | 4.2M | 6.46 | |
Mersana Therapeutics Call Option (MRSN) | 0.4 | $25M | 7.5M | 3.29 | |
Kinnate Biopharma | 0.4 | $24M | 8.0M | 3.03 | |
2seventy Bio Common Stock (TSVT) | 0.4 | $24M | 2.4M | 10.12 | |
Uniqure Nv SHS (QURE) | 0.4 | $24M | 2.1M | 11.46 | |
Rapt Therapeutics (RAPT) | 0.4 | $23M | 1.3M | 18.70 | |
Amicus Therapeutics (FOLD) | 0.4 | $23M | 1.9M | 12.56 | |
Alx Oncology Hldgs (ALXO) | 0.4 | $22M | 2.9M | 7.51 | |
Ikena Oncology (IKNA) | 0.4 | $21M | 3.2M | 6.56 | |
Adicet Bio (ACET) | 0.4 | $20M | 8.3M | 2.43 | |
Decibel Therapeutics | 0.3 | $19M | 4.9M | 3.85 | |
Arcutis Biotherapeutics (ARQT) | 0.3 | $18M | 1.9M | 9.53 | |
Neuropace (NPCE) | 0.3 | $18M | 4.0M | 4.49 | |
Ventyx Biosciences (VTYX) | 0.3 | $18M | 541k | 32.80 | |
Corvus Pharmaceuticals (CRVS) | 0.3 | $16M | 6.9M | 2.29 | |
Fusion Pharmaceuticals | 0.3 | $15M | 3.1M | 4.67 | |
X4 Pharmaceuticals (XFOR) | 0.3 | $14M | 7.1M | 1.94 | |
Kezar Life Sciences (KZR) | 0.2 | $13M | 5.5M | 2.45 | |
Aerovate Therapeutics (AVTE) | 0.2 | $13M | 757k | 17.15 | |
Argenx Se Sponsored Adr (ARGX) | 0.2 | $13M | 33k | 389.73 | |
Morphic Hldg (MORF) | 0.2 | $12M | 209k | 57.33 | |
Verastem Com New (VSTM) | 0.2 | $11M | 1.5M | 7.44 | |
Immatics SHS (IMTX) | 0.2 | $11M | 967k | 11.54 | |
Goodrx Hldgs Com Cl A (GDRX) | 0.2 | $9.9M | 1.8M | 5.52 | |
Regeneron Pharmaceuticals (REGN) | 0.2 | $9.7M | 14k | 718.54 | |
Galecto (GLTO) | 0.2 | $9.7M | 3.8M | 2.52 | |
Passage Bio (PASG) | 0.2 | $9.5M | 10M | 0.94 | |
Akero Therapeutics (AKRO) | 0.2 | $9.3M | 200k | 46.69 | |
Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $9.3M | 15M | 0.62 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $9.1M | 1.2M | 7.76 | |
Gh Research Ordinary Shares (GHRS) | 0.2 | $8.7M | 736k | 11.87 | |
Gilead Sciences (GILD) | 0.1 | $7.7M | 100k | 77.07 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $6.0M | 117k | 51.00 | |
Ys Biopharma Ordinary Shares (LSB) | 0.1 | $5.9M | 4.3M | 1.38 | |
Cullinan Oncology (CGEM) | 0.1 | $5.9M | 545k | 10.76 | |
Cutera (CUTR) | 0.1 | $5.9M | 387k | 15.13 | |
Scholar Rock Hldg Corp (SRRK) | 0.1 | $5.5M | 736k | 7.54 | |
Adagio Therapeutics (IVVD) | 0.1 | $5.5M | 5.3M | 1.05 | |
Nextcure (NXTC) | 0.1 | $4.9M | 2.7M | 1.80 | |
Alkermes SHS (ALKS) | 0.1 | $4.7M | 151k | 31.30 | |
Inspiremd (NSPR) | 0.1 | $4.7M | 1.9M | 2.51 | |
Vigil Neuroscience (VIGL) | 0.1 | $4.2M | 449k | 9.40 | |
Arrowhead Pharmaceuticals (ARWR) | 0.1 | $4.2M | 117k | 35.66 | |
Apollomics Cl A Shs (APLM) | 0.1 | $3.8M | 663k | 5.73 | |
Bioatla (BCAB) | 0.1 | $3.5M | 1.2M | 3.00 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $2.9M | 2.2M | 1.31 | |
Synlogic | 0.0 | $2.6M | 6.0M | 0.43 | |
Revance Therapeutics (RVNC) | 0.0 | $2.5M | 100k | 25.31 | |
Essa Pharma Com New (EPIX) | 0.0 | $2.5M | 922k | 2.70 | |
Acutus Medical (AFIB) | 0.0 | $2.4M | 2.6M | 0.89 | |
Elevation Oncology (ELEV) | 0.0 | $2.3M | 1.5M | 1.52 | |
Bolt Biotherapeutics (BOLT) | 0.0 | $2.0M | 1.5M | 1.28 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $1.8M | 773k | 2.39 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.0 | $1.6M | 4.6M | 0.36 | |
Calcimedica Com New (CALC) | 0.0 | $1.2M | 297k | 4.01 | |
Tg Therapeutics Call Option (TGTX) | 0.0 | $1.1M | 46k | 24.84 | |
Heron Therapeutics (HRTX) | 0.0 | $931k | 803k | 1.16 | |
Singular Genomics Systems In | 0.0 | $449k | 541k | 0.83 | |
Harpoon Therapeutics | 0.0 | $441k | 621k | 0.71 | |
Altimmune Com New (ALT) | 0.0 | $353k | 100k | 3.53 | |
Nektar Therapeutics Call Option (NKTR) | 0.0 | $296k | 515k | 0.58 |